This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health-Care Reformer: Under the Radar

BOSTON ( TheStreet) -- Companies that are able to reduce the country's exorbitant health-care costs will prove to be lucrative investments. One pint-sized company to consider is Emergent Group (LZR), owner of PRI Medical Technologies, which provides surgical equipment on a fee-for-service basis. The Sun Valley, California-based firm focuses on independent hospitals that are unable to afford specialized surgical tools, specifically, advanced laser technologies.

Emergent Group is minute, with a market value of $52 million and fiscal 2008 revenue of around $23 million. A company of such small stature presents unique investment risks, principally, thin trading volume. Just 9,500 Emergent shares exchange daily, making it a comparatively illiquid security. However, the company offers a lesser-known growth story and sound fundamentals. Over the past three years, Emergent has increased revenue 25% annually, on average, and boosted net income 37% a year.

Its business isn't only profitable, enjoying a gross margin of 47%, but sensible. Hospitals incur a hefty cost for surgical equipment. And purchasing such equipment entails risks: What if demand for operations declines? What if a superior technology emerges? What if the equipment is damaged? A health-care center is required to bear the aforementioned risks when it buys new equipment. Contracting with PRI Medical Technologies eliminates those risks in a cost-effective manner.

In addition, Emergent offers expertise to accompany its rentals, providing hospitals with technical staff experienced in the application and maintenance of equipment. Emergent Group is an appealing investment because it's built upon the maxim of specialization. By focusing on one area of health care and investing its time and money appropriately, it offers a compelling value proposition: providing hospitals, and their patients, with access to state-of-the-art treatments at a reduced cost.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.08 0.55%
GOOG $695.81 0.50%
TSLA $234.18 0.80%
YHOO $35.97 -0.11%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs